Want to see IN:ASTERDM full AI Analyst Report?
ASTERDM Stock Chart & Stats
₹615.20
-₹6.20(-1.19%)
At close: 4:00 PM EST
₹615.20
-₹6.20(-1.19%)
Day’s Range― - ―
52-Week Range₹519.80 - ₹847.95
Previous CloseN/A
Volume549.11K
Average Volume (3M)57.99K
Market Cap
₹414.16B
Enterprise Value₹334.28K
Total Cash (Recent Filing)₹13.27B
Total Debt (Recent Filing)₹22.20B
Price to Earnings (P/E)104.2
Beta0.46
Next Earnings
Aug 06, 2026EPS Estimate
2.3Next Dividend Ex-DateN/A
Dividend Yield0.51%
Share Statistics
EPS (TTM)7.53
Shares Outstanding518,121,030
10 Day Avg. Volume86,592
30 Day Avg. Volume57,995
Financial Highlights & Ratios
PEG Ratio-0.96
Price to Book (P/B)7.55
Price to Sales (P/S)7.44
P/FCF Ratio171.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)12.14
Revenue Forecast (FY)₹57.21B
Bulls Say, Bears Say
Bulls Say
Diversified Care NetworkAster’s multi-channel footprint (hospitals, clinics, diagnostics, pharmacies) creates durable revenue diversification and cross-sell advantages. This structural integration stabilizes patient flows, captures downstream pharmacy and diagnostics revenue, and reduces reliance on any single service line over months.
Improving LeverageA material decline in debt-to-equity to ~0.49 materially improves financial flexibility and lowers interest burden. This stronger balance sheet supports capital spending, facility investment and potential M&A while reducing refinancing risk over the 2–6 month horizon.
Margin Recovery And Revenue GrowthHigher operating margins and renewed revenue growth indicate improving core profitability. If sustained, these margins support internal funding for expansion and improve resilience to reimbursement pressure, making earnings generation more durable over coming quarters.
Bears Say
Earnings VolatilityMarked swings in reported profits (including an unusual FY2025 spike) reduce visibility into underlying operating performance. Such volatility complicates forecasting, weakens confidence in recurring earnings quality, and raises the risk that FY2026 improvements are not fully repeatable.
Inconsistent Cash ConversionCash generation has improved but remains inconsistent: FCF is a modest share of earnings and operating cash flow coverage has fluctuated. Persistent working-capital swings limit reliable internal funding for capex, debt service or dividends and can stress liquidity when volumes shift.
History Of Meaningful DebtAlthough leverage fell recently, the company’s history of higher indebtedness and uneven returns on equity signals residual balance-sheet risk. If earnings or cash flow soften, refinancing or covenant pressure could constrain strategic flexibility over the medium term.
Aster DM Healthcare Ltd. News
ASTERDM FAQ
What was Aster DM Healthcare Ltd.’s price range in the past 12 months?
Aster DM Healthcare Ltd. lowest stock price was ₹519.80 and its highest was ₹847.95 in the past 12 months.
What is Aster DM Healthcare Ltd.’s market cap?
Aster DM Healthcare Ltd.’s market cap is ₹414.16B.
When is Aster DM Healthcare Ltd.’s upcoming earnings report date?
Aster DM Healthcare Ltd.’s upcoming earnings report date is Aug 06, 2026 which is in 13 days.
How were Aster DM Healthcare Ltd.’s earnings last quarter?
Aster DM Healthcare Ltd. released its earnings results on Apr 30, 2026. The company reported ₹2.7 earnings per share for the quarter, beating the consensus estimate of ₹1.6 by ₹1.1.
Is Aster DM Healthcare Ltd. overvalued?
According to Wall Street analysts Aster DM Healthcare Ltd.’s price is currently Overvalued.
Does Aster DM Healthcare Ltd. pay dividends?
Aster DM Healthcare Ltd. pays a Semiannually dividend of ₹3 which represents an annual dividend yield of 0.51%. See more information on Aster DM Healthcare Ltd. dividends here
What is Aster DM Healthcare Ltd.’s EPS estimate?
Aster DM Healthcare Ltd.’s EPS estimate is 2.3.
How many shares outstanding does Aster DM Healthcare Ltd. have?
Aster DM Healthcare Ltd. has 518,121,030 shares outstanding.
What happened to Aster DM Healthcare Ltd.’s price movement after its last earnings report?
Aster DM Healthcare Ltd. reported an EPS of ₹2.7 in its last earnings report, beating expectations of ₹1.6. Following the earnings report the stock price went up 0.279%.
Which hedge fund is a major shareholder of Aster DM Healthcare Ltd.?
Currently, no hedge funds are holding shares in IN:ASTERDM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aster DM Healthcare Ltd.
Aster DM Healthcare Ltd. operates as an international healthcare provider with a significant presence in India and other global regions. The company's operations are segmented across hospitals, clinics, retail pharmacies, and other diversified services. It delivers a comprehensive range of medical care, from fundamental primary care to highly specialized quaternary services, supported by a vast infrastructure. This network includes 29 hospitals, 120 clinics, 371 retail pharmacies, 114 laboratories, and numerous patient experience centers, all operating under well-known brands such as Aster, Medcare, and Access. Beyond direct patient care, the company also provides healthcare retailing, diagnostic testing, digital health solutions, and medical education. Established in 1987, Aster DM Healthcare maintains its corporate headquarters in Dubai, United Arab Emirates.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―